Ultralife Corporation
NASDAQ:ULBIElectrical Equipment & Parts
+$0.08 today
- Market cap
- $261.13M
- Beta
- 0.76
- P/E (TTM)
- -12.9
- EPS (TTM)
- -$0.49
Volume 0.10M
Average 0.05M
ULBI EPS (Basic)
Net income attributable to common shareholders divided by the weighted average basic shares outstanding.
Ultralife CorporationNASDAQ: ULBI
EPS (Basic) · Q1 FY2026 · quarter ended Mar 2026
EPS (Basic) turns negative
Q1 FY2026 EPS (Basic) was -$0.03, compared with $0.11 a year earlier. Trailing-twelve-month EPS (Basic) was -$0.5.
Context
- EPS (Basic) increased in 1 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether EPS (Basic) reaches the consensus estimate from 1 analysts of $0.86 (+345.7%) for the fiscal year ending Dec 2026, a step up from the -192.1% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- -$0.03+94.0% QoQ
- Last fiscal yearDec 2025
- -$0.35-192.1% YoY
- LTMMar 2026
- -$0.5-256.9% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | -124.6% | +259.8% | +384.5 pp |
| 1 year | -192.1% | +345.7% | +537.8 pp |
| 3-year CAGR | — | — | — |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EPS (Basic) history
USD · from the income statement
- Latest · FY2025
- (0.35) USD
- Year-over-year change
- -192.1%
| Period | Period end | EPS (Basic) | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (0.35) | -192.1% |
| FY2024 | 2024-12-31 | 0.38 | -13.6% |
| FY2023 | 2023-12-31 | 0.44 | +6045.9% |
| FY2022 | 2022-12-31 | (0.01) | +49.3% |
| FY2021 | 2021-12-31 | (0.01) | — |
EPS (Basic) vs competitors
How ULBI compares with its peers on the latest reported figures
- ULBI's LTM Mar 2026 EPS (Basic) of -$0.5 is the 6th highest of the 7 companies compared; the peer median is -$0.08.
- Its year-over-year change of -256.9% is the 6th highest of 7, against a peer median of +13.3%.
| Company | Period | LTM | YoY | 3-year CAGR |
|---|---|---|---|---|
| LTM Mar 2026 | $3.96 | +42.4% | +82.1% | |
| LTM Mar 2026 | $0.47 | +88.0% | -20.9% | |
| FY2026 | $0.03 | -92.7% | — | |
| LTM Mar 2026 | -$0.19 | -4571.4% | — | |
| LTM Jan 2026 | -$0.19 | +22.2% | — | |
| LTM Mar 2026 | -$0.5 | -256.9% | — | |
| LTM Mar 2026 | -$0.76 | +4.3% | — | |
| Peer median (excluding ULBI) | -$0.08 | +13.3% | +30.6% | |
Competitors are the stored peer set for ULBI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 98.27M | 131.84M | 158.64M | 164.46M | 191.16M |
| Cost of Revenue | 73.63M | 102.44M | 119.44M | 122.14M | 146.66M |
| Gross Profit | 24.64M | 29.4M | 39.2M | 42.31M | 44.5M |
| Gross Margin | 25.1% | 22.3% | 24.7% | 25.7% | 23.3% |
| Research & Development | 6.83M | 7.08M | 7.53M | 8.27M | 9M |
| Selling, General & Admin | 17.78M | 22.19M | 22.19M | 24.08M | 26.28M |
| Operating Expenses | 24.61M | 29.27M | 29.73M | 32.35M | 35.28M |
| Depreciation & Amortization | 3.54M | 4.46M | 3.91M | 4.16M | 5.5M |
| EBITDA | 3.63M | 4.96M | 15.04M | 14.4M | 1.05M |
| EBITDA Margin | 3.7% | 3.8% | 9.5% | 8.8% | 0.6% |
| Operating Income | 35K | 129K | 9.48M | 9.97M | 9.22M |
| Operating Margin | 0.0% | 0.1% | 6.0% | 6.1% | 4.8% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 242K | 951K | 2.02M | 1.94M | 3.95M |
| Other Income / Expenses | (186K) | (575K) | (358K) | (1.66M) | (17.62M) |
| Income Before Tax | (151K) | (446K) | 9.12M | 8.3M | (8.4M) |
| Pre-Tax Margin | -0.2% | -0.3% | 5.7% | 5.0% | -4.4% |
| Income Tax Expense | 79K | (326K) | 1.95M | 1.89M | (2.45M) |
| Net Income | (234K) | (119K) | 7.2M | 6.31M | (5.9M) |
| Net Margin | -0.2% | -0.1% | 4.5% | 3.8% | -3.1% |
| EPS (Basic) | (0.01) | (0.01) | 0.44 | 0.38 | (0.35) |
| EPS (Diluted) | (0.01) | (0.01) | 0.44 | 0.38 | (0.35) |
| Weighted Avg Shares | 16.04M | 16.13M | 16.36M | 16.56M | 16.64M |
| Weighted Avg Shares (Diluted) | 16.04M | 16.13M | 16.23M | 16.77M | 16.64M |
Ultralife Corporation
NASDAQ:ULBI
Intrinsic Alpha fair value
Locked
Current Price
$15.67
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.